Bioenergy centres working towards biofuel goals

At present in India, there are three bioenergy centers established by the department of biotechnology (DBT) to ensure that long term targets of producing cost-effective biofuels are achieved through R&D

biofuel

Multi-disciplinary research to be conducted using cutting-edge technology

"Through R&D network projects, support is being given to Biohydrogen, Biobutanol and algal bio-fuels," stated the union minister of state for science and technology, Dr Jitendra Singh recently in the parliament.

The DBT has established three Bio-energy Centers including DBT-ICT Center for Energy Biosciences, Institute of Chemical Technology, Matunga, Mumbai, Maharashtra; DBT-IOC Centre for Advanced Bio-energy Research, R&D Center, Indian Oil Corporation Limited, Faridabad, Haryana and DBT-ICGEB Center for Advanced Bio-Energy Research, International Center for Genetic Engineering and Biotechnology (ICGEB), New Delhi.

The main objectives of the above three Bio-energy Centers are to conduct multi-disciplinary bio-energy research involving biology, chemical science and material science; develop technology for second generation bio-fuels; deploy bio-fuel technologies with existing capabilities to scale up and to perform cutting edge research using Synthetic and Systems biology approaches towards the development of novel technology for bio-fuel production.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

BusinessWire India.com - Healthcare & biotechnology

Bwi-logo

MTaI Welcomes PMO's Intervention on the Forthcoming National Medical Device

Sunday, 23 Apr 2017   |   Medical Technology Association of India (MTaI)

Business Wire IndiaWe welcome the PMO’s intervention on the National Medical Device Policy (NMDP) .

Replicor discloses achievement of 1 year functional control of HBV and

Friday, 21 Apr 2017   |   Replicor Inc.

Business Wire India Replicor Inc., a privately held biopharmaceutical company targeting a cure for chronic

AWARE Gleneagles Global Hospitals Announces the Launch of Neuro Stroke

Friday, 21 Apr 2017   |   Gleneagles Global Hospitals, a Parkway Pantai Enterprise

Business Wire IndiaAWARE Gleneagles Global Hospitals, a Parkway Pantai Enterprise today announced the

BusinessWire India.com - Pharmaceutical

Bwi-logo

Replicor discloses achievement of 1 year functional control of HBV and

Friday, 21 Apr 2017   |   Replicor Inc.

Business Wire India Replicor Inc., a privately held biopharmaceutical company targeting a cure for chronic

AWARE Gleneagles Global Hospitals Announces the Launch of Neuro Stroke

Friday, 21 Apr 2017   |   Gleneagles Global Hospitals, a Parkway Pantai Enterprise

Business Wire IndiaAWARE Gleneagles Global Hospitals, a Parkway Pantai Enterprise today announced the

BusinessWire India.com - Medical Devices

Bwi-logo

MTaI Welcomes PMO's Intervention on the Forthcoming National Medical Device

Sunday, 23 Apr 2017   |   Medical Technology Association of India (MTaI)

Business Wire IndiaWe welcome the PMO’s intervention on the National Medical Device Policy (NMDP) .

AWARE Gleneagles Global Hospitals Announces the Launch of Neuro Stroke

Friday, 21 Apr 2017   |   Gleneagles Global Hospitals, a Parkway Pantai Enterprise

Business Wire IndiaAWARE Gleneagles Global Hospitals, a Parkway Pantai Enterprise today announced the

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email

X